Picture of Kang Stem Biotech Co logo

217730 Kang Stem Biotech Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Kang Stem Biotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-19,746-21,827-20,176-23,221-7,990
Depreciation
Amortisation
Non-Cash Items9384536951,097-7,428
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1,820506-3,2541,711-6,795
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-13,994-16,994-18,864-16,498-18,987
Capital Expenditures-3,054-4,650-847-1,409-593
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items32,903-20,12517,083-89515,607
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities29,849-24,77516,236-2,30415,014
Financing Cash Flow Items-452-0.005-61.200.099
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-13,56739,286-23119,977884
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,288-2,427-2,8611,175-3,089